Federal Vaccine Advisory Committee Votes to End Universal Hep B Vaccine Recommendation for Babies
The Federal Vaccine Advisory Committee has voted 8-3 to discontinue the universal hepatitis B vaccine recommendation for newborns, shifting to a targeted approach for infants born to hepatitis B-positive mothers. This decision, pending approval from the CDC director, reflects a growing trend towards personalized healthcare recommendations amid a broader political movement advocating for individual health choices. Experts emphasize that the risk of infection for babies born to negative-tested mothers is extremely low, prompting a recommendation for parents to consider potential vaccine risks carefully. This change aligns with recent efforts by certain states, notably Florida, to eliminate vaccine mandates, fostering a debate on government intervention in personal health decisions.
Dive Deeper:
The Advisory Committee on Immunization Practices (ACIP) determined that newborns of hepatitis B-positive mothers should still receive the vaccine, while those of negative-status mothers can consult their doctors instead.
Professor Retsef Levi highlighted that the risk of hepatitis B infection for babies born to mothers with negative test results is negligible, estimated at 'one in several millions.'
This decision is part of the Trump administration's Make America Healthy (MAHA) movement, which aims to challenge traditional health recommendations and prioritize individual choice.
In September, the ACIP also altered guidance for the coronavirus vaccine, allowing individuals to make personal decisions regarding vaccination.
Florida's Surgeon General Joseph Ladapo has announced state efforts to end all vaccine mandates, questioning the authority of government to dictate personal health choices.
The change in hepatitis B vaccination guidelines is indicative of a larger shift in public health policy towards more individualized and less mandated health interventions.